MI Visit the ASPET Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lakatta, E. G.
Right arrow Articles by Sollott, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lakatta, E. G.
Right arrow Articles by Sollott, S. J.
Molecular Interventions 2:431-446 (2002)
© 2002 American Society of Pharmacology and Experimental Therapeutics

Review

The "Heartbreak" of Older Age

Edward G. Lakatta and Steven J. Sollott

Laboratory of Cardiovascular Science Gerontology Research Center Intramural Research Program National Institute on Aging National Institutes of Health, Baltimore, MD 21224

Correspondence: Address correspondence to EGL. E-mail lakattae{at}grc.nia.nih.gov; fax (410) 558-8150.



   SUMMARY
TOP
 Summary
An Integrated View of...
 Cardiac Aging In Animal...
 Impaired Ischemic...
 CONCLUSION
 References
 
It is estimated that by 2035, nearly one in four individuals in the United States will be sixty-five years of age or older. Hypertension, atherosclerosis, and resultant chronic heart failure reach epidemic proportions among older persons, and the clinical manifestations and the prognoses of these worsen with increasing age. The reason is that, in older individuals, specific pathophysiological mechanisms that underlie these diseases become superimposed on heart and vascular substrates that are modified by the process of aging. In other words, cardiovascular aging is "risky." An understanding of how age, per se, modifies cardiovascular structure and function is critical to the prevention or treatment of cardiovascular diseases in the older person.


   AN INTEGRATED VIEW OF AGE-ASSOCIATED CHANGES IN THE HUMAN HEART IN THE ABSENCE OF CLINICAL DISEASE
TOP
 Summary
 An Integrated View of...
Cardiac Aging In Animal...
 Impaired Ischemic...
 CONCLUSION
 References
 
HEART STRUCTURE and FUNCTION AT REST
A unified interpretation of the cardiac changes that accompany advancing age in otherwise healthy persons suggests that, at least in part, these are adaptive, occurring to some extent in response to arterial changes that occur with aging (Figure 1Go) (1) . Aging leads to arterial stiffening that results in enhanced pulse-wave velocity and early reflected pulse-waves. These produce a late augmentation in arterial systolic pressure, a reduced or maintained diastolic pressure in the presence of a mild increase in peripheral vascular resistance (PVR), and an increase pulse pressure, accompanied by aortic dilatation and wall thickening. Increases in the thickness of the left ventricle (LV) wall, largely due to an increase in ventricular myocyte size and increased vascular impedance, moderate the increase in LV wall tension. Modest increases in collagen levels also occur with aging.



View larger version (27K):
[in this window]
[in a new window]
  		Figure 1. Arterial and cardiac changes that occur with aging in healthy humans. One interpretation (flow of arrows) of the constellation is that vascular changes lead to cardiac structural and functional alterations that maintain cardiac function. L, left; LV, left ventricular. From (1).

 
Prolonged contraction of the thickened LV wall maintains a normal ejection time in the presence of the late augmentation of aortic impedance. This preserves the systolic cardiac pumping function at rest. One disadvantage of prolonged contraction is that, at the time of the mitral valve opening, myocardial relaxation is relatively more incomplete in older than in younger individuals and causes the early LV filling rate to be reduced in older individuals. Structural changes and functional heterogeneity occurring within the LV with aging may also contribute to this reduction in peak LV filling rate. However, concomitant adaptations—left atrial enlargement and an enhanced atrial contribution to ventricular filling—compensate for the reduced early filling and prevent a reduction of the end diastolic volume (EDV). Potential age-associated changes in the tissue levels or responses [to growth factors, catecholamines, angiotensin II, endothelin, tumor growth factor ß (TGFß ), or fibroblast growth factor (FGF)] that influence myocardial or vascular cells or their extracellular matrices may also have a role in the schema depicted in Figure 1Go.

CARDIOVASCULAR RESERVE
Heart-rate acceleration and impaired augmentation of blood ejection from the LV, accompanied by an acute modest increase in LV EDV, are the most dramatic changes in cardiac reserve capacity that occur with aging in healthy, community-dwelling persons (Table 1Go). Mechanisms that underlie the age-associated reduction in maximum ejection fraction are multifactorial and include: 1) a reduction in intrinsic myocardial contractility, 2) an increase in vascular afterload, 3) a diminished effectiveness of the autonomic modulation of both LV contractility and arterial afterload, and 4) arterial-ventricular load mismatching. (Ventricular load is the opposition to myocardial contraction and the ejection of blood; afterload is the component of load that pertains to the time following excitation, as opposed to preload, prior to excitation.) Although these age-associated changes in cardiovascular reserve, per se, are insufficient to produce clinical heart failure, they do affect its clinical presentation—that is, the threshold for symptoms and signs, and the severity and prognosis of heart failure secondary to any level of disease burden (e.g., chronic hypertension that causes either systolic or diastolic heart failure).


View this table:
[in this window]
[in a new window]
  		TABLE 1. EXHAUSTIVE UPRIGHT EXERCISE CHANGES IN AEROBIC CAPACITY AND CARDIAC REGULATION BETWEEN AGES OF 20 AND 80 YEARS IN HEALTHY MEN aND WOMEN
 

   CARDIAC AGING IN ANIMAL MODELS
TOP
 Summary
 An Integrated View of...
 Cardiac Aging In Animal...
Impaired Ischemic...
 CONCLUSION
 References
 
CARDIOVASCULAR STRUCTURE
Cellular and molecular mechanisms that are implicated in age-associated changes in myocardial structure and function in humans have been studied largely in rodents (Table 2Go). The altered cardiac structure that evolves with aging in rodents includes an increase in LV mass, due to myocyte enlargement (2) , and proliferation of the matrix where the myocytes reside, which may be linked to alteration of cardiac fibroblast number or function. The number of cardiac myocytes becomes reduced, owing to necrosis predominately, or apoptosis (3) . Stimuli thought to cause cardiac cell enlargement in aging rodents include an age-associated increase in vascular load (due to arterial stiffening) and stretching of cells caused by the death and loss of neighboring myocytes (4) . Stretching of cardiac myocytes and fibroblasts initiates growth-factor-dependent signaling (by angiotensin II or TGFß ), and, in some cases, apoptosis (5) .


View this table:
[in this window]
[in a new window]
  		TABLE 2. MYOCARDIAL CHANGES WITH ADULT AGING IN RODENTS
 
CELL EXCITATION, CA2+REGULATION, AND CONTRACTION
Coordinated changes in the function or expression of proteins that regulate several key steps of cardiac cell excitation-contraction coupling occur in the rodent heart with aging and result in a prolonged action potential (AP), a prolonged cytosolic calcium (Cai ) transient following excitation, and a prolonged contraction (Table 2Go; Figure 2Go) (6 –8) . Both the apparent number and the activity of individual cardiac L-type Ca2+ channels increase with age in the rat (9) . The total L-type current inactivates more slowly in myocytes from older versus younger rats (9 , 10) , and this, as well as reductions in outwardly directed K+ currents (10) , might partially account for the prolonged AP of the former. Shorter APs in myocytes from old rat hearts reduce the Cai transient amplitude. This is attributable to a reduction in sarcoplasmic reticulum (SR) Ca2+ load (sequestered Ca2+ ), which may arise from reduced Ca2+ influx via L-type Ca2+ channels (ICaL ) and increased Ca2+ extrusion by the sarcolemmal Na+ -Ca2+ exchanger (Figure 3Go) (11) .



View larger version (25K):
[in this window]
[in a new window]
  		Figure 2. Differences in various aspects of excitation-contraction coupling mechanisms measured between adult (6–9 months) and senescent (24–26 months) rat hearts. A. Transmembrane action potential, and (B) isometric contraction [from (6) ]. C. Cytosolic calcium transient, measured by a change in the luminescence of aequorin injected into several cells comprising the muscle preparation [from (7) ]. D. Sarcoplasmic reticulum Ca2+ uptake rate [from (8) ].

 


View larger version (13K):
[in this window]
[in a new window]
  		Figure 3. Schematic representation of the role of age-dependent action potential (AP) prolongation on intracellular Ca2+ (Ca2+i) regulation in rat ventricular myocytes. Compared to young rats (4–6 months, left) old rats (23–24 months, middle) display a similar amplitude of the Ca2+i transient triggered by a markedly prolonged AP. Relative to stimulation with their long, native AP, stimulation of old rat ventricular myocytes with a short, "young type" AP (right) increases the amplitude of L-type Ca2+ current (ICa ) but reduces its time integral and diminishes the amplitude and rate of relaxation of the Ca2+i transient. Thus, it appears that ventricular myocytes of old rats utilize AP prolongation to sustain youthful Ca2+i regulation. From (11) .

 
The prolonged Cai that occurs with aging is explained, in part, by a reduction in the rate of Ca2+ sequestration by the SR (Figure 2DGo). This is attributable to a reduced transcription of the gene coding for the sarcoplasmic reticulum Ca2+ pump, Serca2 (1) . The abundance of transcripts of the cardiac Na+ -Ca2+ exchanger (NCX-1), which serves as the main trans-sarcolemmal Ca2+ extrusion mechanism, is increased nearly fifty percent in senescent (twenty-four month) compared to the young adult (six month) rat hearts (12) . Age-associated prolonged Ca2+ transient and heart contraction may impair myocardial relaxation during early diastole and may underlie the reduction in early diastolic filling rate that accompanies advancing age.

The expression of cardiac myosin heavy chain (MHC) isoforms changes over time in the senescent rat heart with the ß isoform becoming predominant; myosin Ca2+ -ATPase activity declines concomitant with the decline in {alpha} MHC content (11) . MHC gene expression can be regulated through binding of the thyroid hormone receptor (THR)—a member of a superfamily of receptors that includes retinoic acid receptors (RARs), vitamin D receptors, and retinoid X receptors (RXRs)—to thyroid response elements in gene 5’ flanking regions. A significant reduction (approximately fifty percent) in the amounts of THRß and RXR{gamma} mRNA transcripts and proteins occurring between six and twenty-four months has been observed in hearts of senescent rats (13) .

The altered composite cellular phenotype (Table 2Go), consisting of contractions with reduced velocity and a prolonged time-course, stems from the elevation of cytosolic [Ca2+ ] that follows a prolonged action potential (AP), is adaptive rather than degenerative. This is so because myocardial shortening at reduced velocity is energy efficient. This altered pattern of Ca2+ regulation and myosin protein expression allows the myocardium of older hearts to generate force and active stiffness for a longer time following excitation (13) . The prolonged isovolumic relaxation period in the healthy aging human heart (14) may be partly attributable to prolonged Ca2+ -dependent contractile protein activation, enabling the continued ejection of blood during late systole, a beneficial adaptation with respect to enhanced central arterial stiffness and early reflected pulse-waves (Figure 1Go) (1) .

REDUCED ACUTE CELLULAR RESPONSE TO STRESS
The acute reserve function of cardiac myocytes may be recruited through enhanced Ca2+ influx into that cell following excitation. An acute excess of myocardial Ca2+ loading leads to dysregulation of Ca2+ homeostasis, impaired diastolic and systolic function, arrhythmias, and cell death (15). The Ca2+ load in each cell is determined by membrane structure and permeability characteristics, the intensity of stimuli that modulate Ca2+ influx or efflux, and the presence of reactive oxygen species (ROS), which affect both membrane structure and function. Excessive cytosolic Ca2+ loading occurs during physiologic and pharmacologic scenarios that increase Ca2+ influx [for example, rapid beating (tachycardia), neurotransmitters, post-ischemic reperfusion, or oxidative stress] (16 , 17).

CELLULAR ß-ADRENERGIC SIGNALING
Deficits in myocardial ß -adrenergic receptor (ß AR) signaling occur with aging (1) : reduced myocardial contractile response to either ß1 AR and ß2 AR stimulation is observed (18 –20) . This is due to inability of ß AR to augment the Cai to the same extent in cells of senescent hearts as compared to cells from younger adult hearts (18) , and can be attributed to reduced numbers of L-type sarcolemmal Ca2+ channels, leading to a smaller increase in Ca2+ influx in "senescent" hearts (Figure 4Go) (18 –21) . The decreased postsynaptic responses of aged myocardial cells stimulated with ß -adrenergic agonists may arise from multiple changes in the molecular and biochemical steps that couple the ß AR to downstream effectors. However, the defect in this signaling pathway in rodents of advanced age appears to be at the point of Gs -mediated coupling of the ß -adrenergic receptor to adenylyl cyclase, and to changes in adenylyl cyclase. The defect leads to deficient cAMP production and to impaired activation of protein kinase A, which normally activates key proteins that augment cardiac contractility (19) . The desensitization of ß AR signaling in advanced-age rodents does not appear to be mediated by increased ß -adrenergic receptor kinase (ß ARK) or increased Gi activity (19) . Under conditions of high-intensity ß -adrenergic stimulation, isolated hearts, cardiac muscle, and myocytes exhibit signs of Ca2+ overload (see below). The older heart exhibits a reduced threshold for this catecholamine-dependent cardiotoxicity (21 , 22)



View larger version (35K):
[in this window]
[in a new window]
  		Figure 4. The efficacy of ß adrenergic receptor stimulation withers with advancing age. A. The effect of norepinephrine on the maximum rate of isometric tension development in isolated trabeculae from hearts of varying age. From (21). B. Velocity of cell shortening, and C. the maximum rate of increases of the Indo-1 fluorescence transient, an index of sarcoplasmic reticulum Ca2+ release into the cytosol, during the electrically stimulated twitch in single cardiac myocytes isolated from the hearts of rats of varying ages and loaded with the fluorescent probe, Indo-1. From (18). D. Norepinephrine increases the L-type sarcolemmal channel current (ICa ). across a range of activating steps to different membrane potentials in single vascular cells potential decline with aging, the norepinephine concentration was 1 x 10-7 M. From (18) . E. Treatment with norepinephrine (NE) increases phosphorylation of troponin I (TNI) in suspensions of heart cells isolated from hearts of rats of varying age. From (20).

 
TACHYCARDIA
In myocytes from older hearts, enhanced Ca2+ influx, impaired relaxation, and increased diastolic tone occur during tachycardia (Figure 5Go) (23 –26) . Studies in rodents have demonstrated that impaired relaxation and impaired Ca2+ sequestration that occur with aging can be reduced by increased expression of Serca2 (Figure 5Go) (23 , 24 , 27 , 28) .



View larger version (11K):
[in this window]
[in a new window]
  		Figure 5. Dependence of LV diastolic pressure (LVDP) in adult hearts (• , n=5), senescent hearts ({blacksquare} , n=4), and senescent hearts infected with Ad.SERCA2a ( {blacktriangleup} , n=6). From (28).

 
During graded increases of [Ca2+ ] in the fluid perfusing the heart there is a reduced threshold for the occurrence of manifestations of Ca2+ overload in senescent (twenty-four-month old) versus younger adult (six-to-eight-month old) rat hearts (Figure 6Go) (16) . Young and old hearts exhibit little difference in developed pressure (DP), end diastolic pressure (EDP), or half relaxation time (RT1/2 ) when bathed in 1.5 mM Ca2+ and given gentle electrical stimulation (Figure 6A, BGo), and these hearts exhibit no aftercontractions—that is, no spontaneous contractions that follow the main contraction in response to the action potential—as exemplified in Figure 6CGo. Initially, increases in [Cao ] result in a strengthened heart beat due to increased Ca2+ influx through L-type Ca2+ channels and to reduced Ca2+ efflux through Na+ -Ca2+ exchange. But, as [Cao ] is progressively increased, the DP response becomes biphasic: increasing, plateauing, and then decreasing. The maximum increase in DP with increasing [Cao ] is less in twenty-four-month-old than in six-to-eight-month-old hearts (Figure 6AGo). Additionally, in twenty-four-month-old hearts, the plateau and decrease in DP occur at a lower [Cao ] than in younger hearts. Thus, the [Cao ] response–systolic function curve is significantly shifted leftward, to lower [Ca] in old versus young hearts.



View larger version (32K):
[in this window]
[in a new window]
  		Figure 6. Reduced Ca2+ tolerance of senescent hearts. A. Developed pressure (DP) and end-diastolic pressure (EDP) in response to increasing perfusate Ca2+ concentration {[Cao ]} in young and old hearts during stimulation at 2.0 Hz. Responses of both DP and EDP significantly differ with age by repeated-measures analysis of variance. B. Half-relaxation time in young and old hearts in response to an increase in [Cao ] at 2.0-Hz stimulation. Response differs with age. C. Chart recording of left ventricular pressure during and after cessation of electrical stimulation. Note the occurrence after cessation of stimulation in 8 mM [Cao ] of a "hyperrelaxation" and aftercontractions (arrows), followed by a slow decay in diastolic pressure, which eventually reaches the RP level (not shown) D. Aftercontractions occurrence after cessation of electrical stimulation at 2.0 Hz in young and old hearts as a function of [Cao ]. E. Spontaneous ventricular fibrillation (VF) occurrence during pacing at 2.0 Hz as a function of [Cao ]. F. Spontaneous contractile waves generated by spontaneous Ca2+ oscillations in single isolate ventricular myocytes from senescent hearts occur more frequently than in those from young adult hearts as [Cao ] is increased. From (16).

 
Diastolic function also becomes impaired in older hearts during scenarios that lead to enhanced Ca2+ increase into the cell. RT1/2 decreases in young hearts as [Cao ] increases, but in senescent hearts, it does not change or increases (Figure 6BGo). EDP in young hearts decreases slightly as [Cao ] increases from 1.5 to 3 mM, and then gradually increases only back to the initial value as [Cao ] is increased further (Figure 6AGo). However, in twenty-four-month-old hearts, the lesser absolute increase of DP to increasing [Cao ] (Figure 6AGo) is accompanied by a greater elevation in EDP compared to six-to-eight-month-old hearts.

The occurrence of aftercontractions (Figure 6CGo, arrows )—driven by spontaneous SR Ca2+ release, another sign of Ca2+ overload (29) —increases as [Cao ] increased (Figure 6DGo). In twenty-four-month-old hearts, the likelihood of aftercontractions is significantly greater than in younger hearts (Figure 6DGo). Spontaneous Ca2+ oscillations are manifested as spontaneous Ca2+ or contractile waves (Figure 6FGo), and the asynchronous force oscillations driven by spontaneous Ca2+ oscillations occur with increasing frequency as [Cao ] rises. Thus, asynchronously occurring cytosolic Ca2+ oscillations become increasingly fused (15) . This summation phenomenon also produces the aftercontraction (Figure 6CGo) and its precursor, the "hyperrelaxation" of diastolic force that follows the main contribution caused by the action potential (Figure 6CGo). This results in a resting pressure (RP) that, in the absence of beating, is greater than EDP or the pressure between beats during stimulation. Spontaneous Ca2+ release activates the Na+ -Ca2+ exchanger, leading to spontaneous depolarizations and arrhythmias (15) . Figure 6EGo shows that Ca2+ -dependent spontaneous ventricular fibrillation occurs in older but not younger hearts. This trilogy of signs caused by cell Ca2+ overload—reduced systolic performance, measured as developed pressure (DP), increased EDP, and increased likelihood for arrhythmia—is a final common scenario for diverse pathologies that cause heart failure (30) . In fact, the experimental paradigm (Figure 6Go) leads to acute diastolic and systolic heart failure.

The reduced threshold for Ca2+ overload is a disadvantageous outcome of the aforementioned age-associated adaptation that occurs in the cells of senescent heart (and also in young animals chronically exposed to arterial pressure overload). Causes of reduced Ca2+ tolerance of the older heart include 1) changes in the amounts of proteins that regulate Ca2+ flux, in part, due to altered gene expression (Table 2Go), 2) to an age-associated alteration in the composition of membranes in which Ca2+ regulatory proteins reside, which includes an increase in the ratio of {omega}6 :{omega}3 polyunsaturated fatty acids (PUFAs) in membranes (31) , or 3) to the increased production of ROS following stress.

CHANGES IN MEMBRANE LIPID COMPOSITION WITH AGING
Ca2+ influx and efflux among intracellular organelles and between intracellular Ca2+ storage sites and the cytosol are governed by the function of proteins within the sarcolemma or organelle membranes; the function of these proteins depends upon their conformation and position within these membranes, which, in turn, is determined by the lipid milieu within the membrane. An increase in the content of arachidonic acid (a {omega}6 PUFA) and a reduction in docosahexaenoic acid (a {omega}3 PUFA) membranes derived from total heart homogenates or from isolated mitochrondria occur with aging (31 , 32) . The age-associated shift in membrane PUFAs can be reversed or exaggerated by dietary interventions (Table 3Go).


View this table:
[in this window]
[in a new window]
  		TABLE 3. PUFA AND PHOSPHOLIPID CONTENT IN MITOCHONDRIAL MEMBRANES FROM YOUNG AND OLD RAT HEARTS
 
Studies indicate that the composition of PUFAs in membranes affects the ion permeability of those membranes (33) . Membranes enriched in {omega}3 or {omega}6 PUFAs are associated, respectively, with a reduced or enhanced susceptibility to Ca2+ overload. The addition of {omega}3 PUFAs to isolated ventricular myocytes in vitro protects against Ca2+ overload (34) . Mechanisms of the later effect may be related to the effects of {omega}3 PUFAs on ion-channel properties (35 , 36) . The decline in the content of cardiac-cell-membrane {omega}3 PUFAs with aging may result in increased vulnerability to Ca2+ overload and other Ca2+ -dependent defects. Indeed, the protective effects of {omega}3 PUFAs against myocardial Ca2+ overload and fatal arrhythmia following ischemia have been demonstrated both in old animals and in younger animals with diets containing high amounts of saturated fat (32 , 37 –40) (Figure 7Go).



View larger version (12K):
[in this window]
[in a new window]
  		Figure 7. Influence of age and dietary fat on the duration of ventricular fibrillation (VF) during reperfusion. The influence of dietary fat on myocardial vulnerability to arrhythmia was examined using coronary artery occlusion and reperfusion in the anesthetized rat as a whole animal model of ventricular fibrillation (VF) and sudden cardiac death. Animals were fed a reference (REF) diet alone or supplemented 12% by weight with tuna fish oil (TFO) (rich in {omega}3 PUFAs), sunflower seed oil (SSO) (rich in {omega}6 PUFAs), or sheep perirenal fat (SF) (rich in saturated fatty acids). Feeding periods of 6, 12, and 18 months and a total of 108 rats were used. The incidence of ventricular fibrillation in occlusion was reduced from 46% of REF animals to 6% and 21% in TFO and SSO groups, respectively, and increased to 68% in the SF-fed rats. The incidence of ventricular tachycardia was also reduced by TFO and SSO. The duration of arrhythmic episodes was increased by SF and reduced by TFO and SSO. The incidence of fibrillation on reperfusion of acutely ischemic myocardium (15 min. occlusion) was significantly reduced by TFO only (12%, REF = 50%, SSO = 30%, SF = 70%). Severity of arrhythmias increased with age as did the extent of dietary influence. Mortality from fibrillation, which only occurred in rats aged twelve months or older (REF = 13%), was increased by SF (43%) mainly in reperfusion (38%) but did not occur in TFO or SSO. These results indicate the potential benefit of dietary modification to include a higher proportion of polyunsaturated fat, especially fish oil, in reducing risk of sudden cardiac death. From (32).

 
INCREASED ROS GENERATION IN THE AGED HEART
A third cause for manifestation of a reduced threshold for Ca2+ overload in the old heart is increased intracellular generation of ROS. Mitochondrial production of ROS in the heart, and mitochondrial dysfunction associated with reperfusion, appear to increase with age (Figure 8AGo) (31 , 41 –45) . Furthermore, several studies indicate that reperfusion that follows ischemia generates ROS and that exogenous application of ROS to cells causes Ca2+ overload, ATP depletion, rigor (i.e., cellular stiffening caused by interlocking of actin and myosin), and occurrence of mitochondrial membrane-permeability transition (MPT) (17) . The MPT involves Ca2+ -dependent opening of the permeability transition pore (PTP), a nonselective, high-conductance channel in the mitochondrial inner membrane that causes the loss of the proton motive force in the respiratory chain and the failure to generation ATP. ROS generated within mitochondria play a role in causing MPT. The release of mitochondrial contents into the cytosol—resulting from the MPT induction—can lead to high [Cai ] and to the generation of additional ROS, whereby necrosis and/or apoptosis are initiated and cell death ensues.



View larger version (30K):
[in this window]
[in a new window]
  		Figure 8. Experimental assessment of membrane-permeablity transistion in individual in situ mitochondria by photoexcited ROS production. A. Age-associated differences in the effect of ischemia and reperfusion on ADP-dependent mitochodrial respiration. Mitochondria were isolated and respiratory activities were assessed; glutamate supported State 3 respiration after perfusion (P), ischemia (I), or reperfusion (R) of hearts from 8- and 24-month-old rats. From (45) . B . Confocal linescan imaging of fluorescence in tetramethylrhodamine methyl ester (TMRM) loaded single rat cardiac myocyte, at 2 Hz along a 25 µ m longitudinal segment encompassing approximately twenty mitochondria; time progresses from left to right. TMRM fluorescence serves as the index of mitochondrial membrane potential, {Delta}{Psi} . The apparent dark regions between horizontal columns are extra mitochondrial spaces between individual mitochondria (approximately half-sarcomere spacing). The sudden dissipation of TMRM fluorescence (i.e., white-to-black transitions at certain points in time) in individual mitochondria indicates the loss of {Delta}{Psi} due to MPT induction. A representative individual mitochondrion is delimited showing its MPT occurrence after approximately 90 sec of photoexcitation. C. Mitochondria from cardiac myocytes of aged (24-month old) rats are more susceptible to ROS-induction of the MPT vs. those from young (3-month old). Cells were examined as in Panel A , and represent the average from 8–10 cells in each group. D. SDS/gel electrophoresis and Western blot analysis of protein from cardiac mitochondria in the experiment in Figure 8AGo. Only mitochondria from 24-month-old reperfused hearts exhibited protein modified by hydroxynoneal (HNE). Thus, HNE-induced change of mitochondrial enzymes might underlie the exaggerated age-associated decline in mitochondrial state 3 respiration during reperfusion observed in Panel A . From (45) . HNE was detected by HPLC assay in cardiac mitochondria isolated from 6- and 24-month-old rats treated to either {omega}3 PUFA or {omega}6 PUFA rich diets for 6 weeks. Hearts (n=8) were subjected to 15-min low-flow global ischemia and reperfused for 30 min prior to isolation of mitochondria. HNE was detected in mitochondria isolated from normoxic controls at a concentration less than 1 pmol/mg mitochondrial protein. E. HNE was detected by HPLC assay in cardiac mitochondria isolated from 6- and 24-month-old rats treated to either {omega}3 PUFA or {omega}6 PUFA-rich diets for 6 weeks. Hearts (n=8) were subjected to fifteen minutes of low-flow global ishcemia and reperfused for thirty minutes prior to isolation of mitochondria. HNE was detected in mitochondria isolated from normoxic controls at a concentration less than 1 pmol/mg mitochondrial protein.

 
Technical limitations had precluded a more precise examination of the local production of ROS in earlier studies and thus could not establish a direct link from ROS to local cellular effects within living, intact cardiac cells. However, newer techniques utilizing chemiluminescence and sequential imaging have revealed that real-time ROS production in liver, during ischemic reperfusion, increases with age (46) . Additionally, more precise methods have been developed that label mitochondrial membranes with fluorescent molecules that generate ROS when excited by visible light laser. The inclusion of a probe that is oxidized by the local production of ROS (e.g., dichlorofluorescein) permits detection of ROS produced by such photoexcitation. Labeling of mitochondria with a membrane-potential-sensitive fluorescent probe permits simultaneous monitoring of ROS generation and mitochondrial membrane potential within cells. Recent studies employing these techniques have discovered a phenomenon referred to as "ROS-induced ROS release" (47) . In other words, the initial or "trigger" ROS generated by the laser excitation of the fluorescent ROS source leads to an amplification of ROS production by the mitochondria themselves. This amplification is associated with induction of the MPT and collapse of the mitochondrial membrane-potential (Figure 8BGo), which renders the mitochondrial membrane permeable to bulk movement of ions, larger molecules, and water between the cytosol and the mitochondrial matrix. Cells from senescent hearts have a substantially lower threshold for the generation of ROS-induced ROS release and less likelihood of the MPT (Figure 8CGo).

ROS, such as the hydroxyl radical (·OH), are highly reactive and generally short-lived species. Therefore, they might be expected to cause damage at or near the site of their formation. Membrane PUFAs undergo lipid peroxidation by ROS, producing various aldehydes, alkenals, and hydroxyalkenals, such as malonaldehyde and 4-hydroxy-2-nonenal (HNE) (48) . HNE, potentially the most reactive of these compounds, is formed by superoxide reactions with membrane {omega}6 PUFAs and reacts with protein sulfhydryl groups to induce altered protein conformation (45 , 48 , 49) . In contrast to many ROS species, HNE is rather long-lived and can therefore diffuse from the site of its origin in membranes to affect potential targets distant from the initial site of ROS production (48) . Thus, if membrane bilayer PUFAs are converted to lipid hydroperoxides, then lipid peroxidation, per se, may be viewed as an "amplifier" for the initial ROS. Furthermore, the reactive aldehydes generated in this process may well act as "toxic second messengers" of the complex chain reactions that follow ROS production (48) .

Because the mitochondrial respiratory chain represents a major subcellular source of ROS during reperfusion of ischemic myocardium (45) , and because ischemic-reperfusion has been associated with decreased rates of NADH-linked, ADP-dependent respiration (50 , 51) , mitochondrial membranes are likely targets of lipid peroxidation and HNE-mediated enzymatic dysfunction. The concentration of HNE is increased in the reperfused post-ischemic myocardium (49) .

HNE modification of mitochondrial proteins occurs exclusively in hearts isolated from senescent rats (Figure 8EGo), but it has not been established whether ROS-induced peroxidation of mitochondrial membranes leading to the production of HNE (Figure 8DGo) is related to the amplification of ROS and "mitochondrial catastrophe." Recent studies show that exposure of intact cardiac mitochondria to HNE leads to decreased NADH-linked respiration (52) partly due to HNE-dependent inactivation of {alpha} -ketoglutarate dehydrogenase and pyruvate dehydrogenase. These enzymes contain lipoic acid residues that are prime targets for HNE (52) . Recent evidence indicates age-dependent inactivation of {alpha} -ketoglutarate dehydrogenase during reperfusion (53) .

PUFAs differ with respect to their susceptibility to lipid peroxidation. Indeed, {omega}6 rather than {omega}3 PUFA appear to be preferred targets of ROS-induced peroxidation that produces HNE (Figure 8EGo). Thus, the increase in {omega}6 :{omega}3 PUFA that occurs with aging may be a mechanism for increased HNE production following ischemia/reperfusion (I/R), but this effect can be markedly attenuated by an {omega}3 PUFA-rich diet (Figure 8EGo). Notably, an {omega}3 PUFA-rich diet also prevents the age-linked decrement of the mitochondria-specific membrane phospholipid cardiolipin (31) , a crucial cofactor for cytochrome c oxidase and adenine nucleotide translocase (ANT) activity (54) . ANT may participate in the formation of a nonspecific membrane pore through a Ca2+ -mediated, cyclophilin-D–dependent conformational change in ANT (55) . Cyclophilin-D binding to ANT increases following oxidative stress that enhances the Ca2+ -dependent formation of the PTP, which induces MPT. Adenine nucleotides located in the mitochondrial matrix bind to ANT and decrease the sensitivity of the PTP to Ca2+ , but this effect is antagonized by modification of specific thiol groups on ANT—by oxidative stress products such as HNE or by thiol reagents such as carboxyatractyloside—to the extent that MPT induction may be enhanced (55) .

In summary, the amounts and ratios of each class of proteins involved in cell ion-homeostasis, the lipid milieu of membranes in which these proteins reside, and the lower threshold requirement to produce ROS and ROS-derived alkenes change with aging and reduce the threshold for acute Ca2+ -overload that occurs within the older heart. An overview of changes in the aging heart that predispose it to a reduced threshold for abnormal Ca2+ handling during acute stress is shown in Figure 9Go. With advancing age, various constitutive changes occur in cardiac cells that can make a substantial impact on cardiovascular function, reducing the cellular capacity to tolerate and adapt to stress such as ischemia/reperfusion. Notable among these changes are a relative decrease in the {omega}3 :{omega}6 PUFA content ratio in cellular membranes, enhanced cellular production of ROS, and alterations in proteins governing Ca2+ mobilization, especially the decreased expression or function of SERCA2 and Na+ -Ca2+ exchange proteins. These changes lead to disturbances in excitation-contraction coupling (prolonged action potential and Ca2+ transient) and in intracellular Ca2+ compartmentalization (abnormal regulation of systolic Ca2+ and increased diastolic [Ca2+ ]; increased mitochondrial [Ca2+ ] (CaM ) leading, in turn, to spontaneous Ca2+ -oscillations and arrhythmias. These and other changes lead to mitochondrial dysfunction that may impair energy metabolism (with diminishing ATP production) together with excessive ROS production. Overproduction of ROS, and the inability to scavenge excess ROS, leads to damaging lipid-peroxidation and relatively more diffusible, but still potent, reactive intermediates, such as HNE, which affect widespread protein targets and amplify Ca2+ dysregulation and mitochondrial abnormalities. Finally, the abnormal Ca2+ handling and reactive species buildup can induce the MPT with the release of contents that activate a sequence of events leading to cell death (by apoptosis or necrosis). Recent research has demonstrated that these effects of aging are exacerbated by poor nutritional habits but can be ameliorated by diets substituting {omega}3 PUFAs for {omega}6 PUFAs (Table 3Go, Figure 7Go). Other promising avenues to ameliorate these aging changes include gene therapy to restore the expression of Ca2+ -regulatory proteins and the effective use of antioxidants.



View larger version (28K):
[in this window]
[in a new window]
  		Figure 9. Overview of changes in the aging heart that predispose to a reduced threshold for abnormal Ca2+ handling. (See text for details) From (17).

 
REDUCED CHRONIC ADAPTATIVE CAPACITY OF THE OLDER HEART
Many of the multiple changes in cardiac structure, excitation, myofilament activation, contraction mechanisms, Ca2+ dysregulation, deficient ß AR signaling, and altered gene expression of proteins involved in excitation-contraction coupling that occur with aging (Table 2Go) also occur in the hypertrophied myocardium of younger animals with experimentally induced chronic hypertension (1 , 56) and in failing animal or human hearts, in which they have been construed as an adaptive response to a chronic increase in LV loading. The expression of atrial natriuretic (57) and opioid (58) peptides—molecules that are usually produced in response to chronic stress—is increased in the senescent rodent heart (Figure 10Go) (57 , 59) . This suggests that the old rodent heart is "stressed" on a chronic basis. When additional chronic mechanical stresses that evoke substantial myocardial hypertrophy, such as pressure or volume overload, are imposed upon the older heart, the response in many instances is reduced. There is evidence that transcriptional events associated with hypertrophic stressors become altered with advancing age: the nuclear binding activity of the transcription factor NF-{kappa} B is increased and that of another transcription factor, Sp1, is diminished (60) . Because these transcription factors each influence the expression of several genes, they may contribute to the pattern of gene expression observed in the hearts of senescent rodents as well as dictate the limits of adaptive responses to the imposition of additional chronic stress. The acute induction of both immediate-early and late genes that are expressed during the hypertrophic response is blunted in hearts of aged rats after aortic constriction (61 , 62) . Similarly, the acute induction of heat shock protein genes in response to either ischemia or heat shock is reduced in hearts of senescent rats (63 , 64) . A similar loss of adaptive capacity is observed in younger rats that have utilized a part of their reserve capacity prior to a growth factor challenge (65) .



View larger version (14K):
[in this window]
[in a new window]
  		Figure 10. Peptides reflecting chronic myocardial stress increase with aging. A. Atrial natriuretic factor (ANF) mRNA levels in left ventricles (LV) of male Wistar rats. From (57). B. Preproenkephalin (PNK) mRNA levels in left ventricles of male Wistar rats. From (59).

 

   IMPAIRED ISCHEMIC PRECONDITIONING IN THE HUMAN ELDERLY HEART
TOP
 Summary
 An Integrated View of...
 Cardiac Aging In Animal...
 Impaired Ischemic...
CONCLUSION
 References
 
The most potent form of cardiac protection known against prolonged periods of ischemia, such as during coronary artery occlusion of an acute myocardial infarction (MI), results from the activation of endogenous mechanisms triggered by brief episodes of transient ischemia closely preceding the infarct (66) . This phenomenon is known as ischemic preconditioning (PC) and occurs in most species, including humans (67) . Patients with preinfarction angina, which is arguably the clinical manifestation of "spontaneous" PC, experience a better clinical outcome after MI than those without preceding angina. During the past decade, multiple studies in acute MI patients undergoing coronary reperfusion with thrombolytic agents were able to show that patients who experienced bouts of preinfarction angina manifest significant clinical benefits, such as improved LV function and reduced myocardial infarct size, episodes of congestive heart failure and cardiogenic shock, arrhythmias, and in-hospital mortality, compared to those without angina (68 –74) . However, the aging process appears to reduce or eliminate the protection afforded the adult heart by PC as demonstrated in experimental animal studies (75 , 76) as well as in several clinical studies (77 , 78) . It is possible that this age-associated reduction in the protective efficacy of PC by preinfarction angina could explain at least part of the higher mortality in the elderly—as compared to younger adult patients—who have coronary heart disease (79) . Intriguingly, in the rat model (80) as well as in elderly patients (79) , physical activity and exercise training restores the cardiac protective effect of PC and preinfarction angina otherwise lost during aging.


   CONCLUSION
TOP
 Summary
 An Integrated View of...
 Cardiac Aging In Animal...
 Impaired Ischemic...
 CONCLUSION
References
 
Our understanding of the age-associated alterations in vascular and cardiac structure and function has advanced at both the cellular and molecular levels, providing valuable clues that may assist in the development of effective therapies to prevent, delay, or attenuate the cardiovascular changes that accompany aging. Many of these age-associated changes are being increasingly recognized as risk factors for cardiovascular diseases. Future efforts to modulate these risks imparted by aging will require the close collaboration of researchers, including molecular cardiologists, cardiovascular physiologists, pharmacologists, and clinically based translational research.


Edward G. Lakatta, MD, (Left) is the Director of the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health. He also holds adjunct appointments as Professor, Department of Physiology, University of Maryland School of Medicine, and Professor, Cardiology Division, Johns Hopkins School of Medicine. The overall goals of his research program are: 1) to study basic mechanisms in cardiac excitation-contraction coupling and how these are modulated by surface receptor signaling pathways in cardiac muscle; 2) to determine mechanisms of normal and abnormal function of vascular smooth muscle and endothelial cells; 3) to identify age-associated changes that occur within the cardiovascular system and to determine the mechanisms for these changes; 4) to study myocardial structure and function and to determine how age interacts with chronic disease states to alter function; and 5) to establish the potentials and limitations of new therapeutic approaches such as gene transfer techniques. He is an Inaugural Fellow of the Council on Basic Cardiovascular Sciences of the American Heart Association, and the recipient of the Eli Lilly Award in Medical Science.

Steven J. Sollott, MD, (Right) is a Senior Investigator and the Head of the Cardioprotection Unit, Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health. He also holds an adjunct appointment as Assistant Professor, Cardiology Division, Johns Hopkins University School of Medicine. His research focuses on the structure and function of cardiovascular cells along three principal lines: 1) mechanisms of cardiac contractility; 2) nature and control of mitochondrial instability during oxidant stress; and 3) cellular changes after vascular injury. One of his more noteworthy findings relates to the observation that paclitaxel (Taxol), a drug used to treat cancer, could markedly attenuate vascular restenosis after angioplasty. Human clinical trials currently in progress in Europe, Asia, and the United States indicate that paclitaxel may prevent human restenosis with minimal toxicity.


   ACKNOWLEDGMENTS
TOP
 Summary
 An Integrated View of...
 Cardiac Aging In Animal...
 Impaired Ischemic...
 CONCLUSION
 References
 
The authors would like to thank Christina R. Link for her secretarial support.


   References
TOP
 Summary
 An Integrated View of...
 Cardiac Aging In Animal...
 Impaired Ischemic...
 CONCLUSION
 References
 

  1. Lakatta, E.G. Cardiovascular regulatory mechanisms in advanced age. Physiol. Rev. 73 , 413–465 (1993).[Free Full Text]
  2. Fraticelli, A., Josephson, R., Danziger, R. et al. Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence. Am. J. Physiol. 257 , H259–H265 (1989).[Abstract/Free Full Text]
  3. Anversa, P., Palackal, T., Sonnenblick, E.H. et al. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ. Res. 67 , 871–885 (1990).[Abstract/Free Full Text]
  4. Lakatta, E.G. Cardiovascular aging research: The next horizons. J. Am. Geriatr. Soc. 47 , 613–625 (1999).[Medline]
  5. Cigola, E., Kastura, J., Li, B. et al. Angiotensin II activates programmed myocyte cell death in vitro. Exp. Cell Res. 231 , 363–371 (1997).[CrossRef][Medline]
  6. Wei, J.Y., Spurgeon, H.A., and Lakatta, E.G. Excitation-contraction in rat myocardium: Alterations with adult aging. Am. J. Physiol. 246 , H784–H791 (1984).
  7. Orchard, C.H. and Lakatta, E.G. Intracellular calcium transients and developed tensions in rat heart muscle. A mechanism for the negative interval-strength relationship. J. Gen. Physiol. 86 , 637–651 (1985).[Abstract/Free Full Text]
  8. Froehlich, J.P., Lakatta, E.G., Beard, E. et al. Studies of sarcoplasmic reticulum function and contraction duration in young and aged rat myocardium. J. Mol. Coll. Cardiol. 10 , 427–438 (1978).
  9. Josephson, I.R., Guia, A., Stern, M.D. et al. Alterations in properties of L-type Ca2+ channels in aging rat heart. J. Mol. Cell. Cardiol. 34 , 297–308 (2002).[CrossRef][Medline]
  10. Walker, K.E., Lakatta, E.G., and Houser, S.R. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc. Res. 27 , 1968–1977 (1993).[Abstract/Free Full Text]
  11. Janczewski, A.M., Spurgeon, H.A., and Lakatta, E.G. Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca2+ regulation. J. Mol. Cell. Cardiol. 34 , 641–648 (2002).[CrossRef][Medline]
  12. Koban, M.U., Moorman, A.F.M., Holtz, J. et al. Expressional analysis of the cardiac Na+ -Ca2+ exchanger in rat development and senescence. Cardiovasc. Res. 37 , 405–423 (1998).[Abstract/Free Full Text]
  13. Spurgeon, H.A., Thorne, P.R., Yin, F.C.P. et al. Increased dynamic stiffness of trabeculae carneae from senescent rats. Am. J. Physiol. 232 , H373–H380 (1977).
  14. Lakatta, E.G. and Levy, D. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises Part 2: The Aging Heart in Health: Links to Heart Disease. Circulation: New Frontiers 2002; in press .
  15. Lakatta, E.G. Functional implications of spontaneous sarcoplasmic reticulum Ca2+ release in the heart. Cardiovasc. Res. 26 , 193–214 (1992).[Free Full Text]
  16. Hano, O., Bogdanov, K.Y., Sakai, M. et al: Reduced threshold for myocardial cell calcium intolerance in the rat heart with aging. Am. J. Physiol. 269 , H1607–H1612 (1995).[Abstract/Free Full Text]
  17. Lakatta, E.G., Sollott, S.J., and Pepe, S. The Old Heart: Operating on the Edge. In: Ageing Vulnerability: Causes and Interventions. Novartis Foundation Symposium 235. John Wiley and Sons, Ltd. , pp. 172–201 (2001).
  18. Xiao, R.-P., Spurgeon, H.A., O’Connor, F. et al. Age-associated changes in ß -adrenergic modulation on rat cardiac excitation-contraction coupling. J. Clin. Invest. 94 , 2051–2059 (1994).
  19. Xiao, R.-P., Tomhave, E.D., Xiangwu, J. et al. Age-associated reductions in cardiac ß1 - and ß2 -adrenoceptor responses without changes in inhibitory G proteins or receptor kinases. J. Clin. Invest. 101 , 1273–1282 (1998).[Medline]
  20. Sakai, M., Danziger, R.S., Staddon, J.M. et al. Decrease with senescence in the norepinephrine-induced phosphorylation of myofilament proteins in isolated rat cardiac myocytes. J. Mol. Cell. Cardiol. 21 , 1327–1336 (1989).[CrossRef][Medline]
  21. Lakatta, E.G., Gerstenblith, G., Angell, C.S. et al. Diminished inotropic response of aged myocardium to catecholamines. Circ. Res. 36, 262–269 (1975).[Abstract/Free Full Text]
  22. Guideri, G., Olivetti, G., Hiler, B., and Ricci, R. Increased incidence of isoproterenol-induced ventricular fibrillation in aging rats. Can. J. Physiol. 65 , 504–508 (1987).[Medline]
  23. Brenner, D.A., Apstein, C.S., and Saupe, K.W. Exercise training attenuates age-associated diastolic dysfunction in rats. Circulation 104 , 221–226 (2001).[Abstract/Free Full Text]
  24. Tate, C.A., Taffet, G.E., Hudson, E.K. et al. Enhanced calcium uptake of cardiac sarcoplasmic reticulum in exercise-trained old rats. Am. J. Physiol. 258 , H431–H435 (1990).[Abstract/Free Full Text]
  25. Lim, C.C., Apstein, C.S., Colucci, W.S. et al. Impaired cell shortening and relengthening with increased pacing frequency are intrinsic to senescent mouse cardiomyocyte. J. Mol. Cell. Cardiol . 32 , 2075–2082 (2000).[CrossRef][Medline]
  26. Zhang, S.J., Zhou, Y.Y., Xiao, R.-P. et al. Age-associated reduction in recovery of the equilibrium state of myocyte length during reduced interstimulus intervals at higher stimulation rates. Biophys. J. 78 , 227A, Abstract 1340-Pos (2000).
  27. Spurgeon, H.A., Steinbach, M.F., and Lakatta, E.G. Chronic exercise prevents characteristic age-related changes in rat cardiac contraction. Am. J. Physiol. 244 , H513–H518 (1983).
  28. Schmidt, U., del Monte, F., Miyamoto, M.I. et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca2+ -ATPase. Circulation 101 , 790–796 (2000).[Abstract/Free Full Text]
  29. Beyer, K. and Klingenberg, M. ADP/ATP carrier protein from beef heart mitochondria has high amounts of tightly bound cardiolipin, as revealed by 31 P nuclear magnetic resonance. Biochemistry 24 , 3821–3826 (1985).[CrossRef][Medline]
  30. Lakatta, E.G. Chaotic behavior of myocardial cells: Possible implications regarding the pathophysiology of heart failure. Perspect. Biol. Med. 32 , 421–433 (1989).[Medline]
  31. Pepe, S., Tsuchiya, N., Lakatta, E.G. et al. PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH. Am. J. Physiol. 276 , H149–H158 (1999).[Abstract/Free Full Text]
  32. McLennan, P., Abeywardena, M., and Charnock, J. The influence of age and dietary fat in animal model of sudden cardiac death. Aust. N.Z. J. Med. 19 , 1–5 (1989).[Medline]
  33. Lakatta, E.G. and Sollott, S.J. Perspectives on mammalian cardiovascular aging: Humans to molecules. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 132 , 699–721 (2002).[CrossRef][Medline]
  34. Hallaq, H., Smith, T., and Leaf, A. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc. Natl. Acad. Sci. U.S.A. 89 , 1760–1764 (1992).[Abstract/Free Full Text]
  35. Bogdanov, K., Spurgeon, H., Vinogradova, T., and Lakatta, E. Modulation of the transient outward current in adult rat ventricular myocytes by polyunsaturated fatty acids. Am. J. Physiol. 274 , H571–H579 (1998).
  36. Pepe, S., Bogdanov, K., Hallaq, H. et al. {varphi}3 polyunsaturated fatty acid modulates dihydropyridine effects on L-type Ca2+ channels, cytosolic Ca2+ , and contraction in adult rat cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 91 , 8832–8836 (1994).[Abstract/Free Full Text]
  37. McLennan, P., Abeywardena, M., and Charnock, J. Influence of dietary lipids on arrhythmia and infarction after coronary artery ligation in rats. Can. J. Physiol. Pharmacol. 63 , 1411–1417 (1985).[Medline]
  38. McLennan, P., Abeywardena, M., and Charnock, J. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am. Heart J. 16 , 709–717 (1988).
  39. McLennan, P., Abeywardena, M., and Charnock, J. Reversal of the arrhythmogenic effects of long-term saturated fatty acid intake by dietary n -3 and n -6 polyunsaturated fatty acids. Am. J. Clin. Nutr. 51 , 53–58 (1990).[Abstract/Free Full Text]
  40. McLennan, P., Bridle, T., Abeywardena, M., and Charnock, J. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am. Heart J. 123 , 1555–1561 (1992).[CrossRef][Medline]
  41. Hansford, R. Bioenergetics in aging. Biochim. Biophys. Acta 726 , 41–80 (1983).[Medline]
  42. Nohl, H., Breuninger, V., and Hegner, D. Influence of mitochondrial radical formation on energy-linked respiration. Eur. J. Biochem. 90 , 385–390 (1978).[Medline]
  43. Sawada, M. and Carlson, J. Changes in superoxide radical and lipid peroxide formation in the brain, heart and liver during the lifetime of the rat. Mech. Aging Dev. 41 , 125–137 (1987).
  44. Sohal, R., Arnold, L., and Sohal, B. Age-related changes in antioxidant enzymes and prooxidant generation in tissues of the rat with special reference to parameters in two insect species. Free Radic. Biol. Med. 10 , 495–500 (1990).
  45. Lucas, D. and Sweda, L. Cardiac reperfusion injury, aging, lipid peroxidation, and mitochondrial dysfunction. Proc. Natl. Acad. Sci. U.S.A. 95 , 510–514 (1998).[Abstract/Free Full Text]
  46. Gasbarrini, A., Pasini, P., Nardo, B. et al. Chemiluminescent real time imaging of post-ischemic oxygen free radicals formation in livers isolated from young and old rats. Free Radic. Biol. Med. 24 , 211–216 (1998).[CrossRef][Medline]
  47. Zorov, D.B., Filburn, C.R., Klotz, L.O. et al. Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192 , 1001–1014 (2000).[Abstract/Free Full Text]
  48. Esterbauer, H., Schaur, R., and Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 , 81–128 (1991).[CrossRef][Medline]
  49. Blasig, I., Grune, T., Schonheit, K. et al. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am. J. Physiol. 269 , H14–H22 (1995).[Abstract/Free Full Text]
  50. Ambrosio, G., Zweier, J., Duilio, C. et al. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J. Biol. Chem. 268 , 18532–18541 (1993).[Abstract/Free Full Text]
  51. Das, D., George, A., Liu, X., and Rao, P. Detection of hydroxyl radical in the mitochondria of ischemic-reperfused myocardium by trapping with salicylate. Biochem. Biophys. Res. Commun. 165 , 1004–1009 (1989).[CrossRef][Medline]
  52. Humphries, K.M., Prakash, A.R., and McNeill, J.H. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. Biochemistry 37 , 552–557 (1998).[CrossRef][Medline]
  53. Lucas, D. and Szweda, L. Declines in mitochondrial respiration during cardiac reperfusion: Age-dependent inactivation of {alpha} -ketoglutarate dehydrogenase. Proc. Natl. Acad. Sci. U.S.A. 96 , 6689–6693 (1999).[Abstract/Free Full Text]
  54. Paradies, G., Ruggiero, F.M., Petrosillo, G. et al. Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria. FEBS Lett. 350 , 213–215 (1994).[CrossRef][Medline]
  55. Halstrup, A., Kerr, P., Javador, S., and Woodfield, K. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury in the heart. Biochim. Biophys. Acta 1366 , 79–94 (1998).[Medline]
  56. Yin, F.C.P., Spurgeon, H.A., Weisfeldt, M.L. et al. Mechanical properties of myocardium from hypertrophied rat hearts. A comparison between hypertrophy induced by senescence and by aortic banding. Circ. Res. 46 , 292–300 (1980).[Free Full Text]
  57. Younes, A., Boluyt, M.O., O’Neill, L. et al. Age-associated increase in rat ventricular ANP gene expression correlates with cardiac hypertrophy. Am. J. Physiol 269 , H1003–H1008 (1995).[Abstract/Free Full Text]
  58. Caffrey, J.L., Boluyt, M.O., Younes, A. et al. Aging, cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat. J. Mol. Cell. Cardiol. 26 , 701–711 (1994).[CrossRef][Medline]
  59. Boluyt, M.O., Younes, A., Caffrey, J.L. et al. Age-associated increase in rat cardiac opioid production. Am. J. Physiol . 265 , H212–H218 (1993).[Abstract/Free Full Text]
  60. Helenius, M., Hänninen, M., Lehtinen, S.K. et al. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-{kappa} B transcription factor in mouse cardiac muscle. J. Mol. Cell. Cardiol. 28 , 487–498 (1996).[CrossRef][Medline]
  61. Takahashi, T., Schunkert, H., lsoyama, S. et al. Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium. J. Clin. Invest . 89 , 939–945 (1992).
  62. Shida, M. and Isoyama, S. Effects of age on c-fos and c-myc gene expression in response to hemodynamic stress in isolated, perfused rat hearts. J. Mol. Cell. Cardiol. 25 , 1025–1035 (1993).[CrossRef][Medline]
  63. Nitta, Y., Abe, K., Aoki, M. et al. Diminished heat shock protein 70 mRNA induction in aged rat hearts after ischemia. Am. Physiol. Soc . 94 , H1795–H1803 (1994).
  64. Boluyt, M.O. and Lakatta, E.G. Cardiovascular Aging in Health. In: Heart Metabolism in Failure, R.A. Altschuld, R.A. Haworth (Eds). JAI Press Inc. , Vol. 4B, pp. 257–303 (1998).
  65. Shunkert, H., Weinberg, E., Bruckschlegel, G. et al. Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J. Clin. Invest . 96 , 2768–2774 (1995).
  66. Murry, C.E., Jennings, R.B., and Reimer, K. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74 , 1124–1136 (1986).[Abstract/Free Full Text]
  67. Kloner, R.A., Bolli, R., Marban, E., Reinlib, L., and Braunwald, E. Medical and cellular implications of stunning, hibernation, and preconditioning. An NHLBI workshop. Circulation 97 , 1848–1867 (1998).[Free Full Text]
  68. Anzai, T., Yoshikawa, T., Asakura, Y. et al. Effect on short-term prognosis and left ventricular function of angina pectoris prior to first Q-wave anterior wall acute myocardial infarction. Am. J. Cardiol. 74 , 755–759 (1994).[CrossRef][Medline]
  69. Anzai, T., Yoshikawa, T., Asakura, Y. et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q-wave myocardial infarction. J. Am. Coll. Cardiol. 26 , 319–327 (1995).[Abstract]
  70. Kloner, R.A., Shook, T., Przyklenk, K. et al. Previous angina alters in-hospital outcome in TIMI 4: A clinical correlate to preconditioning? Circulation 91 , 37–45 (1995).[Abstract/Free Full Text]
  71. Nakagawa, Y., Ito, H., Kitakaze, M. et al. Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: Retrospective clinical evidence of "preconditioning." J. Am. Coll. Cardiol. 25 , 1076–1083 (1995).[Abstract]
  72. Ottani, F., Galvani, M., Ferrini, D. et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 91 , 291–297 (1995).[Abstract/Free Full Text]
  73. Ishihara, M., Sato, H., Tateishi, H. et al. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: Acute angiographic findings and long-term prognosis. J. Am. Coll. Cardiol. 30 , 970–975 (1997).[Abstract]
  74. Kloner, R.A., Shook, T., Antman, E.M., Cannon, C.P., Przyklenk, K., Yoo, K., McCabe, C.H., and Braunwald, E. A prospective temporal analysis of the onset of preinfarct angina versus outcome: An ancillary study in TIMI-9B. Circulation 97 , 1042–1045 (1998).[Abstract/Free Full Text]
  75. Abete, P., Ferrara, N., Cioppa, A. et al. Preconditioning does not prevent post-ischemic dysfunction in aging heart. J. Am. Coll. Cardiol. 27 , 1777–1786 (1996).[Abstract]
  76. Tani, M., Suganuma, Y., Hasegawa, H. et al. Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 95 , 2559–2566 (1997).[Abstract/Free Full Text]
  77. Abete, P., Ferrara, N., Cacciatore, F. et al. Angina-induced protection against myocardial infarction in adult and senescent patients. A loss of preconditioning mechanism in aging heart? J. Am. Coll. Cardiol. 30 , 947–954 (1997).[Abstract]
  78. Ishihara, M., Sato, H., Tateishi, H. et al. Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction. Am. Heart J. 139 , 881–888 (2000).[Medline]
  79. Abete, P., Ferrara, N., Cacciatore, F. et al. High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients. J. Am. Coll. Cardiol. 38 , 1357–1365 (2001).[Abstract/Free Full Text]
  80. Abete, P., Calabrese, C., Ferrara, N. et al. Exercise training restores ischemic preconditioning in the aging heart. J. Am. Coll. Cardiol. 36 , 643–650 (2000).[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
D. B. Zorov, M. Juhaszova, Y. Yaniv, H. B. Nuss, S. Wang, and S. J. Sollott
Regulation and pharmacology of the mitochondrial permeability transition pore
Cardiovasc Res, July 15, 2009; 83(2): 213 - 225.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L.-H. Xie, F. Chen, H. S. Karagueuzian, and J. N. Weiss
Oxidative Stress-Induced Afterdepolarizations and Calmodulin Kinase II Signaling
Circ. Res., January 2, 2009; 104(1): 79 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
L. T. Nguyen, M. J. Rebecchi, L. C. Moore, P. S. A. Glass, P. R. Brink, and L. Liu
Attenuation of Isoflurane-Induced Preconditioning and Reactive Oxygen Species Production in the Senescent Rat Heart
Anesth. Analg., September 1, 2008; 107(3): 776 - 782.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S.-K. Park, G. P. Page, K. Kim, D. B. Allison, M. Meydani, R. Weindruch, and T. A. Prolla
{alpha}- and {gamma}-Tocopherol Prevent Age-Related Transcriptional Alterations in the Heart and Brain of Mice
J. Nutr., June 1, 2008; 138(6): 1010 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. M. Davidson and M. R. Duchen
Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance
Cardiovasc Res, July 1, 2006; 71(1): 10 - 21.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
G. Kristo, Y. Yoshimura, B. J. Keith, R. M. Mentzer Jr., and R. D. Lasley
Aged Rat Myocardium Exhibits Normal Adenosine Receptor-Mediated Bradycardia and Coronary Vasodilation But Increased Adenosine Agonist-Mediated Cardioprotection
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2005; 60(11): 1399 - 1404.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. M. Redfield, S. J. Jacobsen, B. A. Borlaug, R. J. Rodeheffer, and D. A. Kass
Age- and Gender-Related Ventricular-Vascular Stiffening: A Community-Based Study
Circulation, October 11, 2005; 112(15): 2254 - 2262.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J. J. Ochoa, J. L. Quiles, J. R. Huertas, and J. Mataix
Coenzyme Q10 Protects From Aging-Related Oxidative Stress and Improves Mitochondrial Function in Heart of Rats Fed a Polyunsaturated Fatty Acid (PUFA)-Rich Diet
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2005; 60(8): 970 - 975.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Juhaszova, C. Rabuel, D. B. Zorov, E. G. Lakatta, and S. J. Sollott
Protection in the aged heart: preventing the heart-break of old age?
Cardiovasc Res, May 1, 2005; 66(2): 233 - 244.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lakatta, E. G.
Right arrow Articles by Sollott, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lakatta, E. G.
Right arrow Articles by Sollott, S. J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.